• Title/Summary/Keyword: e-technology acceptance

Search Result 298, Processing Time 0.023 seconds

Comparative Quality Traits, Flavor Compounds, and Metabolite Profile of Korean Native Black Goat Meat

  • Shine Htet Aung;Edirisinghe Dewage Nalaka Sandun Abeyrathne;Md. Altaf Hossain;Doo Yeon Jung;Hyun Cheol Kim;Cheorun Jo;Ki-Chang Nam
    • Food Science of Animal Resources
    • /
    • v.43 no.4
    • /
    • pp.639-658
    • /
    • 2023
  • Although goat meat has several health benefits than other red meats but comsumers reluctant it due to its unpleasant flavor. This study aimed to investigate the odorant of goat meat as well as compare the quality traits of meat regarding sex status. The loin meats [non-castrated male (NCM), castrated male (CM), and female (FM)] were collected and stored at 4℃ in a laboratory refrigerator and analyzed on the 1st, 5th, and 8th consecutive days. The moisture content was the lowest and the protein content was highest in FM (p<0.05). Fat and ash content in NCM and FM were similar while lowest in CM. The CIE L* was significantly higher in NCM, but there were no significant differences of CIE a* and CIE b* within groups at initial day. The color intensity increased on the 5th storage day and decreased again after the 8th storage day, except in NCM. NCM displayed the highest thiobarbituric acid reactive substances value (p<0.05), whereas CM displayed a higher pH value than other groups throughout the storage period. Indole levels were the highest in NCM (0.031 mg/kg); however, skatole levels were not significant differences across all treatments (p>0.05). No significant difference was observed in the fatty acid composition between NCM and CM (p>0.05), whereas a significant difference was observed in FM (p<0.05). Most of the water-soluble metabolites showed significant differences between sexes. Overall, sex status effects on quality properties of meat and castration can improve the overall sensory acceptance by reducing goaty flavor of Korean native black goat meat.

A Study on Consumer Awareness and Determinants of Overseas Direct Purchase : Focused on Moderating Effects of Logistics Infrastructure and Market Uncertainty (소비자 특성이 해외직접구매 관심도 결정에 미치는 영향 : 물류인프라 및 시장 불확실성의 조절효과)

  • Cho, Hyuk-Soo;Lee, Jung-Sun
    • International Commerce and Information Review
    • /
    • v.18 no.3
    • /
    • pp.23-43
    • /
    • 2016
  • Many customers of individual countries are interested in overseas direct purchase. B2C is not limited in a domestic market anymore. There are giant online shopping sites such as Amazon and eBay around the world. Many local and overseas customers can access and purchase products via B2C sites. Market size of overseas direct purchase has been dramatically increased. Overseas direct purchase can be closely associated with trade or international commerce due to the massive increase. This study aims at gaining a better understanding of overseas direct purchase in the country-level not customer-level. Specifically, this study examines relationships between overseas direct purchase and customer determinants including openness, innovativeness, and strategic confirmity to normative institution. Also, moderating effect with external environments such as logistics infrastructure and market uncertainty. Relying on RBV, TCA, Institutional theory, and OSAM model, this study justifies how internal and external determinants can increase or decrease consumer awareness on overseas direct purchase.

  • PDF

Bioequivalence of Broadcef Capsule to Cefradine Yuhan Capsule (Cephradine 500 mg) (유한세프라딘 캅셀(세프라딘 500 mg)에 대한 브로드세프 캅셀의 생물학적 동등성)

  • Cho, Hea-Young;Lee, Suk;Kang, Hyun-Ah;Oh, In-Joon;Lim, Dong-Koo;Moon, Jai-Dong;Lee, Yong-Bok
    • Journal of Pharmaceutical Investigation
    • /
    • v.32 no.3
    • /
    • pp.215-221
    • /
    • 2002
  • Cephradine is a first generation cephalosporin and has broad spectrum antibacterial activity against gram-positive and gram-negative microorganisms, through inhibition of bacterial cell wall synthesis. Cephradine is useful for treatment of infections of the urinary and respiratory tract, skin and soft tissues. The purpose of the present study was to evaluate the bioequivalence of two cephradine capsules, Cefradine Yuhan (YuHan Corporation) and Broadcef (Ilsung Pharmaceuticals Co. Ltd.), according to the guidelines of Korea Food and Drug Administration (KFDA). The cephradine release from the two cephradine capsules in vitro was tested using KP VII Apparatus II method with various different kinds of dissolution media (pH 1.2, 4.0, 6.8 buffer solution and water). Twenty normal male volunteers, $23.10{\pm}2.90$ years in age and $67.69{\pm}8.04\;kg$ in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After one capsule containing 500 mg as cephradine was orally administered, blood was taken at predetermined time intervals and the concentrations of cephradine in serum were determined using HPLC method with UV detector. The dissolution profiles of two cephradine capsules were very similar at all dissolution media. Besides, the pharmacokinetic parameters such as $AVC_t,\;C_{max}\;and\;T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters using logarithmically transformed $AVC_t\;and\;C_{max}$ and untransformed $T_{max}$. The results showed that the differences in $AVC_t,\;C_{max}\;and\;T_{max}$ between two capsules based on the Cefradine Yuhan were -2.87%, -0.96% and -4.85%, respectively. There were no sequence effects between two capsules in these parameters. The 90% confidence intervals using logarithmically transformed data were within the acceptance range of 1og(0.8) to log(1.25) $(e.g.,\;log(0.93){\sim}log(1.02)\;and\;log(0.88){\sim}log(1.13)\;for \;AVC_t\;and\;C_{max},\;respectively)$. The 90% confidence interval using untransformed data was within ${\pm}20%$ $(e.g., \;-17.54{\sim}7.78\;for\;T_{max})$. All parameters met the criteria of KFDA guideline for bioequivalence, indicating that Broadcef capsule is bioequivalent to Cefradine Yuhan capsule.

Bioequivalence of Levopid Tablet to Levopride Tablet (Levosulpiride 25 mg) (레보프라이드 정(레보설피리드 25 mg)에 대한 레보피드 정의 생물학적 동등성)

  • Cho, Hea-Young;Kang, Hyun-Ah;Moon, Jai-Dong;Lee, Yong-Bok
    • Journal of Pharmaceutical Investigation
    • /
    • v.32 no.2
    • /
    • pp.127-133
    • /
    • 2002
  • Levosulpiride is the 1evo-enantiomer form of racemic sulpiride, a benzamide derivative selectively inhibiting dopaminergic $D_2$ receptors at the trigger zone both in the central nervous system and in the gastrointestinal tract. The purpose of the present study was to evaluate the bioequiva1ence of two levosulpiride tablets, Levopride (SK Pharmaceutical Co., Ltd.) and Levopid (Dae Won Pharmaceutical Co., Ltd.), according to the guidelines of Korea Food and Drug Administration (KFDA). The levosulpiride release from the two levosulpiride tablets in vitro was tested using KP VII Apparatus II method with various different kinds of dissolution media (pH 1.2, 4.0, 6.8 buffer solution and water). Twenty eight normal male volunteers, $23.82{\pm}3.26$ years in age and $69.13{\pm}8.58$ kg in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After one tablet containing 25 mg of levosulpiride was orally administered, blood was taken at predetermined time intervals and the concentrations of levosulpiride in serum were determined using HPLC method with fluorescence detector. The dissolution profiles of two levosulpiride tablets were very similar at all dissolution media. Besides, the pharmacokinetic parameters such as $AUC_t,\;C_{max}\;and\;T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters using logarithmically transformed $AUC_t\;and\;C_{max}$ and untransformed $T_{max}$. The results showed that the differences in $AUC_t,\;C_{max}\;and\;T_{max}$ between two tablets based on the Levopride were -1.17%, 1.20% and -1.09%, respectively. There were no sequence effects between two tablets in these parameters. The 90% confidence intervals using logarithmically transformed data were within the acceptance range of log(0.8) to log(1.25) $(e.g.,\;log(0.93){\sim}log(1.07)\;and\;log(0.90){\sim}log(1.14)\;for\;AUC_t\;and\;C_{max}$, respectively). The 90% confidence interval using untransformed data was within ${\pm}20%$ $(e.g.,\;-19.47{\sim}16.20\;for\;T_{max})$. All parameters met the criteria of KFDA guideline for bioequivalence, indicating that Levopid tablet is bioequivalent to Levopride tablet.

Bioequivalence of Hanacef Capsule to Duricef Capsule (Cefadroxil 500 mg) (듀리세프 캅셀(세파드록실 500 mg)에 대한 하나세프 캅셀의 생물학적 동등성)

  • Cho, Hea-Young;Lee, Suk;Moon, Jai-Dong;Lee, Yong-Bok
    • Journal of Pharmaceutical Investigation
    • /
    • v.32 no.2
    • /
    • pp.135-140
    • /
    • 2002
  • Cefadroxil is a semi-synthetic cephalosporin active against many Gram-positive and Gram-negative bacteria. The drug has been used for the treatment of the urinary and respiratory tract infections when caused by susceptible strains of the designated microorganism. The purpose of the present study was to evaluate the bioequivalence of two cefadroxil capsules, Duricef (Bo Ryung Pharmaceutical Co. Ltd.) and Hanacef (Korean Pharmaceutical Co. Ltd.), according to the guidelines of Korea Food and Drug Administration (KFDA). The cefadroxil release from the two cefadroxil capsules in vitro was tested using KP VII Apparatus II method with various different kinds of dissolution media (pH 1.2, 4.0, 6.8 buffer solution and water). Twenty four normal male volunteers, $21.58{\pm}2.43$ years in age and $70.74{\pm}10.29$ kg in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After one capsule containing 500 mg as cefadroxil was orally administered, blood was taken at predetermined time intervals and the concentrations of cefadroxil in serum were determined using HPLC with UV detector. The dissolution profiles of two cefadroxil capsules were very similar at all dissolution media. The pharmacokinetic parameters such as $AUC_t,\;C_{max}\;and\;T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters using logarithmically transformed $AUC_t\;and\;C_{max}$ and untransformed $T_{max}$. The results showed that the differences in $AUC_t,\;C_{max}\;and\;T_{max}$ between two capsules based on the Duricef were 0.05%, -5.29% and 4.53%. There were no sequence effects between two capsules in these parameters. The 90% confidence intervals using logarithmically transformed data were within the acceptance range of log(0.8) to log(1.25) $(e.g.,\;log(0.95){\sim}log(1.05)\;and\;log(0.87){\sim}log(1.02)$ for $AUC_t\;and\;C_{max}$, respectively). The 90% confidence interval using untransformed data was within ${pm}20%$ $(e.g.,\;-6.75{\sim}15.74\;for\;T_{max})$. All parameters met the criteria of KFDA guideline for bioequivalence, indicating that Hanacef capsule is bioequivalent to Duricef capsule.

The Impact of Perception on the Difference Between Mobile and Stationary Internet Toward the Intention to Use Mobile Internet (모바일 인터넷과 PC 인터넷의 특성 차이에 대한 인식이 모바일 인터넷 사용 의도에 미치는 영향에 대한 연구)

  • Shin, Hyun-Sik;Song, Yong-Uk;Sung, Nahk-Hyun
    • The Journal of Society for e-Business Studies
    • /
    • v.15 no.3
    • /
    • pp.99-129
    • /
    • 2010
  • The objective of this research is to identify the factors which influence users' intention to use mobile Internet. There are lots of researches based on Technology Acceptance Model trying to identify the factors which have influence on accepting mobile Internet and its related services. These researches, however, have some limitation in the sense that they focus only on the features of mobile Internet itself while users make overall decision after the comparison of a new service channel with existing service channels in many directions. Therefore, we are going to analyze the impact of users' perception on the difference between mobile and stationary Internet toward their intention to use mobile Internet. We identified the features like ubiquitous availability, context awareness, compatibility, friendliness, and economic value from literature review and developed a structural model about the impact of users' perception on the differences of these features between mobile and stationary Internet toward their intention to use mobile Internet through mediate variables such as perceived ease of use, perceived playfulness, and perceived usefulness. After that, we conducted an experimental analysis for the model, and addressed a solution to rev up the usage of mobile Internet based on the results of the analysis.

Bioequivalence of Pinatos Capsule 10 mg to Ketas Capsule 10 mg (Ibudilast 10 mg) (케타스 캡슐 10밀리그램(이부딜라스트 10 밀리그램)에 대한 피나토스 캡슐 10밀리그램의 생물학적동등성)

  • Kang, Hyun-Ah;Kim, Se-Mi;Kang, Min-Sun;Yoo, Dong-Jin;Lee, Sang-No;Kwon, In-Ho;Yoo, Hee-Doo;Lee, Yong-Bok
    • Journal of Pharmaceutical Investigation
    • /
    • v.40 no.2
    • /
    • pp.117-123
    • /
    • 2010
  • Ibudilast, 3-isobutyryl-2-isopropyrazolo[1,5-a]pyridine, is a nonselective inhibitor of cyclic nucleotide phosphodiesterase (PDE). It preferentially inhibits PDE 3A, PDE4, PDE10 and PDE11 as well as a number of the other PDE families, albeit to a lesser extent. Ibudilast is used clinically to treat bronchial asthma and cerebrovascular disorders. Thes e clinical uses are based on the ability of ibudilast to inhibit platelet aggregation, improve cerebral blood flow and attenuate allergic reactions. The purpose of the present study was to evaluate the bioequivalence of two ibudilast capsules, Ketas capsule (Handok Pharmaceuticals Co., Ltd.) and Pinatos capsule (Sam Chun Dang Pharm. Co., Ltd.), according to the guidelines of the Korea Food and Drug Administration (KFDA). The in vitro release of ibudilast from the two ibudilast formulations was tested using KP Apparatus method with various dissolution media. Twenty six healthy male subjects, 23.31${\pm}$1.09 years in age and 70.45${\pm}$8.51 kg in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After a single capsule containing 10 mg as ibudilast was orally administered, blood samples were taken at predetermined time intervals and the concentrations of ibudilast in serum were determined using HPLC/UV detector. The dissolution profiles of two formulations were similar in all tested dissolution media. The pharmacokinetic parameters such as $AUC_t$, $C_{max}$ and $T_{max}$ were calculated, and computer programs (Equiv Test and K-BE Test 2002) were utilized for the statistical analysis of the parameters using logarithmically transformed $AUC_t$, $C_{max}$ and untransformed $T_{max}$. The results showed that the differences between two formulations based on the reference drug, Ketas, were 6.99%, -2.48% and 9.93% for $AUC_t$, $C_{max}$ and $T_{max}$, respectively. There were no sequence effects between two formulations in these parameters. The 90% confidence intervals using logarithmically transformed data were within the acceptance range of log 0.8 to log 1.25 (e.g., log 0.8791~log 1.1861 and log 0.8347~log 1.1199 for $AUC_t$ and $C_{max}$, respectively). Thus, the criteria of the KFDA bioequivalence guideline were satisfied, indicating Pinatos capsule was bioequivalent to Ketas capsule.

The Effect of Individual Motivated Propensity on Perceived Characteristics and Use Intentions for Mobile Medical Service (개인 동기성향의 차이가 스마트폰 의료서비스 사용의도에 미치는 영향에 대한 구조관계 연구)

  • Joh, WonIl;Yoo, ByungTae;Kim, SeungChul
    • The Journal of Society for e-Business Studies
    • /
    • v.19 no.4
    • /
    • pp.169-193
    • /
    • 2014
  • This paper attempts to analyze how the psychological factors would have an effect on the user's intention to make use of the mobile care via smart-phone, identifying the relationships among individual motivation propensity that consists of prevention propensity and promotion propensity, perceived usefulness and ease of use, perceived cost, behavioral use attitude and use intention based on technology acceptance model, and verifying them empirically through the structural equation modeling. The findings are as the followings. First, prevention motivation propensity affects positively on usefulness of smart-phone for mobile care service, but there are no significant indications that it affects on the ease of use and perceived cost. Second, promotion propensity affects positively on perceived ease of use and perceived cost of smart-phone for mobile care service, but there is no significant indication that it affects on perceived usefulness. Third, perceived usefulness and ease of use, and perceived cost affects positively on the use attitude. In sum, this paper confirms that the prevention propensity and promotion propensity might be used as antecedent variables for developing new smart-phone services of mobile care.

An Analysis on Affecting Factors of Healthcare Applications Continuous Usage Intention and their Relationships (헬스케어 어플리케이션 지속적 사용의도 영향 요인 및 요인 간 관계에 대한 분석)

  • Ki, Yeon-Su;Ahn, Sung-Mahn;Cho, Min-Guk;Choi, Byounggu
    • The Journal of Society for e-Business Studies
    • /
    • v.24 no.1
    • /
    • pp.49-89
    • /
    • 2019
  • Many studies have been conducted on adoption of healthcare applications. However, few studies have paid their attention to continuous usage intention of healthcare applications even though success of healthcare applications is determined by Continuous usage intention rather than adoption. Therefore, this study tried to identify the factors affecting the continuous usage intention of healthcare applications and examined the relationship between them empirically. In addition, the role of gender and age in the relationship was investigated. The results showed that self-efficacy and innovation had a significant effect on perceived ease of use of healthcare application, while self-efficacy, health information seeking, and enjoyment had a significant effect on perceived usefulness. Perceived ease of use and usefulness showed positive impact on continuous usage intention of healthcare application. Finally, age and gender had a moderator effect the relationship between perceived usefulness and continuous usage intention. This study is expected to make contributions to the existing research by identifying the factors affecting the Continuous usage intention of healthcare applications, but also to give a guideline for managers who want to provide healthcare application services.

NATURAL ATTENUATION OF HAZARDOUS INORGANIC COMPONENTS: GEOCHEMISTRY PROSPECTIVE (유해 무기질의 자연정화 : 지화학적 고찰)

  • Lee, Suk-Young;Lee, Chae-Young;Yun, Jun-Ki
    • Proceedings of the KSEEG Conference
    • /
    • 2002.06a
    • /
    • pp.81-100
    • /
    • 2002
  • While most of regulatory communities in abroad recognize ' 'natural attenuation " to include degradation, dispersion, dilution, sorption (including precipitation and transformation), and volatilization as governing Processes, regulators prefer "degradation" because this mechanism destroys the contaminant of concern. Unfortunately, true degradation only applies to organic contaminants and short- lived radionuclides, and leaves most metals and long-lived radionuclides. The natural attenuation Processes may reduce the potential risk Posed by site contaminants in three ways: (i)contaminants could be converted to a less toxic form througy destructive processes such as biodegradation or abiotic transformations; (ii) potential exposure levels may be reduced by lowering concentrations (dilution and dispersion); and (iii) contaminant mobility and bioavailability may be reduced by sorption to geomedia. In this review, authors will focus will focul on "sorption" among the natural attenuation processes of hazardous inorganic contaminants including radionuclides. Note though that sorption and transformation processes of inorganic contaminants in the natural setting could be influenced by biotic activities but our discussion would limit only to geochemical reactions involved in the natural attenuation. All of the geochemical reactions have been studied in-depth by numerous researchers for many years to understand "retardation" process of contaminants in the geomedia. The most common approach for estimating retardation is the determination of distrubution coefficiendts ($K_{d}$) of contaminants using parametric or mechanistic models. As typocally used in fate and contaminant transport calculations such as predictive models of the natural attenuation, the $K_{d}$ is defined as the ratio of the contaminant concentration in the surrounding aqueous solution when the system is at equilibrium. Unfortunately, generic or default $K_{d}$ values can result in significant error when used to predict contaminant migration rate and to select a site remediation alternative. Thus, to input the best $K_{d}$ value in the contaminant transport model, it is essential that important geochemical processes affecting the transport should be identified and understood. Precipitation/dissolution and adsorption/desorption are considered the most important geochemical processes affecting the interaction of inorganic and radionuclide contaminants with geomedia at the near and far field, respectively. Most of contaminants to be discussed in this presentation are relatively immobile, i.e., have very high $K_{d}$ values under natural geochemical environments. Unfortunately, the obvious containment in a source area may not be good enough to qualify as monitored natural attenuation site unless owner demonstrate the efficacy if institutional controls that were put in place to protect potential receptors. In this view, natural attenuation as a remedial alternative for some of sites contaminated by hazardous-inorganic components is regulatory and public acceptance issues rather than scientific issue.

  • PDF